A study to determine the cardiovascular effects of different methods of administering the oxytocic drug Syntocinon

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN07452238

Enrollment

Registered

2003-09-12

Start date

2002-11-01

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy and Childbirth: Anaesthesia Pregnancy and Childbirth Anaesthesia

Interventions

Bolus injection (bolus group) vs infusion over 5 min (infusion group)

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Women choosing spinal anaesthesia for elective Caesarean: 15 in control group receiving syntocinon 5 units intravenously (IV) as a bolus after delivery 15 in study group receiving syntocinon 5 units IV continuously over 5 min after delivery

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

Measure	Time frame
Reason for study ie to determine a method that can be used to routinely limit the decrease in blood pressure.	—

Secondary

Measure	Time frame
Not provided at time of registration	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026